Metraipolis › archive › dc_08ee7cbb41d0

Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41601951
DOI
10.3389/fphar.2025.1732996
License (as archived)
solo-consultazione
Archived
2026-11-06T21:19:07.093Z
SHA-256 of the archived text
3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6
Stable URL of this page
https://metraipolis.com/documento/dc_08ee7cbb41d0

How to cite

Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951 — Europe PMC (en), https://europepmc.org/article/MED/41601951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08ee7cbb41d0 (Metraipolis archive dc_08ee7cbb41d0, sha256 3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6)
BibTeX
@misc{dc08ee7cbb41d0,
  title = {Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects — Europe PMC PMID:41601951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08ee7cbb41d0; sha256 3a8698ccb39f8c0babf7c05df7daa9a7de8ca34876482bd646d9e678be6819a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601951. Agents can read the archived copy with the MCP tool read_document.